Development of 132 Ir sources for brachytherapy

Area of Science:

• Nuclear Medicine
• Medical Physics
• Materials Science

Background:

• Brachytherapy is a crucial cancer treatment modality.
• Development of reliable and safe radioactive sources is essential for brachytherapy.
• Previous methods for producing iridium-192 (192Ir) sources had limitations.

Purpose of the Study:

• To develop and optimize production techniques for three types of 192Ir brachytherapy sources: hairpin, single-pin, and seed.
• To ensure the safety and efficacy of the produced 192Ir sources for clinical applications.
• To establish specific radioactivity levels for each source type.

Main Methods:

• Irradiation of platinum-iridium alloy wire, sheathed in a platinum tube, using the JRR-2 or JRR-3 reactor.
• Controlled irradiation conditions to achieve target radioactivity levels for each source type.
• Loading seed targets into polyethylene tubes with nylon spacers for specific treatment techniques.

Main Results:

• Successful production of hairpin, single-pin, and seed 192Ir sources with target radioactivity levels: 0.74 GBq, 0.37 GBq, and 0.037 GBq, respectively.
• The platinum sheath effectively shielded beta-rays, reducing patient radiation exposure.
• Consistent linear radioactivity distribution was achieved for hairpin and single-pin sources.
• No significant impurities or surface contamination were detected in the pre-encapsulated sources.
• Seed targets were effectively prepared into ribbon sources using polyethylene tubes and spacers.

Conclusions:

• Developed techniques enable the production of safe and effective 192Ir brachytherapy sources.
• The platinum encapsulation and controlled irradiation ensure source quality and patient safety.
• The produced sources are suitable for various brachytherapy applications, including novel tumor treatment techniques.